Pfizer

Recent news

• Rating change
  Barclays Maintains Pfizer(PFE.US) With Sell Rating, Maintains Target Price $25
  Market Newswire · 2026/8/14
• Rating change
  BMO Capital Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $30
  Market Newswire · 2026/8/18
• Rating change
  Scotiabank Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $30
  Market Newswire · 2026/8/24
• Rating change
  Bernstein Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $29
  Market Newswire · 2026/8/21
• Pfizer, BioNTech, and Moderna sought to have Bayer's Monsanto mRNA patent lawsuit dismissed, but the judge rejected their motion.
  Zhitong Finance · 2026/9/29
• Bernstein Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $29
  Market Newswire · 2026/9/23
• Company notice
  Pfizer | 4: Statement of changes in beneficial ownership of securities-Director LITTMAN DAN R.
  SEC · 2026/4/28
• Company notice
  Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.
  SEC · 2026/3/4
• Rating change
  Cantor Fitzgerald Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $27
  Market Newswire · 2026/8/5
• Rating change
  Guggenheim Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $31
  Market Newswire · 2026/8/7
• Company notice
  Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.
  SEC · 2026/2/28
• Rating change
  Argus Research Maintains Pfizer(PFE.US) With Buy Rating
  Market Newswire · 2026/8/7
• Rating change
  DZ BANK AG Maintains Pfizer(PFE.US) With Buy Rating
  Market Newswire · 2026/8/6
• Company notice
  Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.
  SEC · 2026/3/6
• BridgeBio (BBIO.US) cardiac therapy acoramidis outperforms Pfizer’s (PFE.US) competitor drug in real-world study
  Zhitong Finance · 2026/9/24
• Rating change
  TD Cowen Upgrades Pfizer(PFE.US) to Buy Rating
  Market Newswire · 2026/8/12
• Pfizer (PFE.US) to share overseas price-hike gains with U.S. government: "Most-Favored-Nation" contract exposed, while over twenty deals remain confidential
  Zhitong Finance · 2026/9/21
• Company notice
  Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.
  SEC · 2026/6/11
• Rating change
  HSBC Maintains Pfizer(PFE.US) With Hold Rating, Raises Target Price to $30
  Market Newswire · 2026/9/10
• Wells Fargo Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $28
  Market Newswire · 2026/9/22
• Dow Jones Top Company Headlines at 9 PM ET: Amazon Pauses Operations With 21 Air After Miami Crash | Pfizer ...
  Dow Jones · 9/14
• Pfizer (PFE.US) Sees Signs of Recovery! New Drug Revenue Surges 18%, but Patent Cliff Remains the Biggest Challenge
  Zhitong Finance · 8/24

Headlines are aggregated automatically and are not independently verified or edited by our team.